Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH): AURORA Phase 3 Study Design: 2942. (October 2019) - Anstee, Quentin M.; Neuschwander‐Tetri, Brent A.; Wong, Vincent Wai‐Sun; Abdelmalek, Manal F.; Younossi, Zobair; Alkhouri, Naim; Yuan, Jiacheng; Pecoraro, Maria Lucia; Seyedkazemi, Star; Fischer, Laurent; Bedossa, Pierre; Goodman, Zachary; et al.